• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腺苷脱氨酶缺乏症中的热点突变

Hot spot mutations in adenosine deaminase deficiency.

作者信息

Hirschhorn R, Tzall S, Ellenbogen A

机构信息

Department of Medicine, New York University Medical School, NY 10016.

出版信息

Proc Natl Acad Sci U S A. 1990 Aug;87(16):6171-5. doi: 10.1073/pnas.87.16.6171.

DOI:10.1073/pnas.87.16.6171
PMID:2166947
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC54494/
Abstract

We have previously characterized mutant adenosine deaminase (ADA; adenosine aminohydrolase, EC 3.5.4.4) enzymes in seven children with partial ADA deficiency. Six children shared common origins, suggesting a common progenitor. However, we found evidence for multiple phenotypically different mutant enzymes. We hypothesized that many of the mutations would be at CpG dinucleotides, hot spots at which spontaneous deamination of 5-methylcytosine results in C to T or G to A transitions. Digestion of DNA from these children with Msp I and Taq I, enzymes recognizing CpG dinucleotides, identified three different mutations, each correlating with expression of a different mutant enzyme. Sequencing of cDNA clones and genomic DNA amplified by polymerase chain reaction confirmed the presence of C to T or G to A transitions at CpG dinucleotides (C226 to T, G446 to A, and C821 to T, resulting in Arg76 to Trp, Arg149 to Gln, and Pro274 to Leu). A "null" mutation, also found in two ADA-deficient severe combined immunodeficient children, was serendipitously detected as gain of a site for Msp I. Simultaneous loss of a site for Bal I defined the precise base substitution (T320 to C, Leu107 to Pro), confirmed by sequence analysis. To determine the true frequency of hot spot mutation in these children, consecutively ascertained through a newborn screening program, we sequenced cDNA from the remaining alleles. Two others were hot spot mutations (C631 to T and G643 to A, resulting in Arg211 to Cys and Ala215 to Thr), each again resulting in expression of a phenotypically different mutant enzyme. Only one additional mutation (previously identified by us) is not in a hot spot. These seven mutations account for all 14 chromosomes in these children. There is thus a very high frequency of hot spot mutations in partial ADA deficiency. Most of these children carry two different mutant alleles. We were able to correlate genotype and phenotype and to dissect the activity of individual mutant alleles.

摘要

我们之前已对7名腺苷脱氨酶(ADA;腺苷氨基水解酶,EC 3.5.4.4)部分缺乏的儿童中的突变酶进行了特征描述。6名儿童有共同的起源,提示有一个共同的祖先。然而,我们发现了多种表型不同的突变酶的证据。我们推测许多突变会发生在CpG二核苷酸处,这是5-甲基胞嘧啶自发脱氨导致C到T或G到A转换的热点。用识别CpG二核苷酸的Msp I和Taq I酶消化这些儿童的DNA,鉴定出三种不同的突变,每种突变都与一种不同突变酶的表达相关。对通过聚合酶链反应扩增的cDNA克隆和基因组DNA进行测序,证实了在CpG二核苷酸处存在C到T或G到A的转换(C226到T、G446到A以及C821到T,分别导致Arg76变为Trp、Arg149变为Gln以及Pro274变为Leu)。在两名ADA缺乏的重症联合免疫缺陷儿童中还偶然发现了一个“无效”突变,表现为获得了一个Msp I位点。同时失去一个Bal I位点确定了精确的碱基替换(T320到C,Leu107变为Pro),序列分析证实了这一点。为了确定通过新生儿筛查项目连续确定的这些儿童中热点突变的真实频率,我们对其余等位基因的cDNA进行了测序。另外两个是热点突变(C631到T和G643到A,分别导致Arg211变为Cys以及Ala215变为Thr),每种突变再次导致一种表型不同的突变酶的表达。只有另外一个突变(之前我们已鉴定出)不在热点区域。这7个突变占了这些儿童所有的14条染色体。因此,在ADA部分缺乏中热点突变的频率非常高。这些儿童中的大多数携带两个不同的突变等位基因。我们能够将基因型与表型相关联,并剖析各个突变等位基因的活性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0ed/54494/a1339ce85916/pnas01041-0175-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0ed/54494/1b6cb2c7c05b/pnas01041-0174-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0ed/54494/90fb70a883bf/pnas01041-0175-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0ed/54494/a1339ce85916/pnas01041-0175-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0ed/54494/1b6cb2c7c05b/pnas01041-0174-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0ed/54494/90fb70a883bf/pnas01041-0175-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0ed/54494/a1339ce85916/pnas01041-0175-b.jpg

相似文献

1
Hot spot mutations in adenosine deaminase deficiency.腺苷脱氨酶缺乏症中的热点突变
Proc Natl Acad Sci U S A. 1990 Aug;87(16):6171-5. doi: 10.1073/pnas.87.16.6171.
2
Paradoxical expression of adenosine deaminase in T cells cultured from a patient with adenosine deaminase deficiency and combine immunodeficiency.
J Clin Invest. 1990 Aug;86(2):444-52. doi: 10.1172/JCI114730.
3
Genetic heterogeneity in adenosine deaminase (ADA) deficiency: five different mutations in five new patients with partial ADA deficiency.腺苷脱氨酶(ADA)缺乏症中的遗传异质性:5例部分ADA缺乏症新患者中的5种不同突变
Am J Hum Genet. 1986 Jan;38(1):13-25.
4
Mutations in the human adenosine deaminase gene that affect protein structure and RNA splicing.影响蛋白质结构和RNA剪接的人类腺苷脱氨酶基因突变。
Proc Natl Acad Sci U S A. 1987 Aug;84(16):5947-51. doi: 10.1073/pnas.84.16.5947.
5
Identification of a point mutation resulting in a heat-labile adenosine deaminase (ADA) in two unrelated children with partial ADA deficiency.在两名患有部分腺苷脱氨酶(ADA)缺乏症的非亲缘儿童中鉴定出一种导致热不稳定腺苷脱氨酶(ADA)的点突变。
J Clin Invest. 1989 Feb;83(2):497-501. doi: 10.1172/JCI113909.
6
Adenosine deaminase (ADA) deficiency due to deletion of the ADA gene promoter and first exon by homologous recombination between two Alu elements.
J Clin Invest. 1988 May;81(5):1323-7. doi: 10.1172/JCI113458.
7
Mutant human adenosine deaminase alleles and their expression by transfection into fibroblasts.突变的人类腺苷脱氨酶等位基因及其通过转染成纤维细胞的表达。
J Biol Chem. 1988 Nov 5;263(31):16291-6.
8
Three new adenosine deaminase mutations that define a splicing enhancer and cause severe and partial phenotypes: implications for evolution of a CpG hotspot and expression of a transduced ADA cDNA.三种新的腺苷脱氨酶突变定义了一个剪接增强子并导致严重和部分表型:对CpG热点进化和转导的ADA cDNA表达的影响
Hum Mol Genet. 1995 Nov;4(11):2081-7. doi: 10.1093/hmg/4.11.2081.
9
Cloning of cDNA sequences of human adenosine deaminase.人腺苷脱氨酶cDNA序列的克隆
Proc Natl Acad Sci U S A. 1983 Dec;80(24):7481-5. doi: 10.1073/pnas.80.24.7481.
10
Novel splicing, missense, and deletion mutations in seven adenosine deaminase-deficient patients with late/delayed onset of combined immunodeficiency disease. Contribution of genotype to phenotype.7例腺苷脱氨酶缺陷型联合免疫缺陷病迟发/延迟发病患者中的新型剪接、错义及缺失突变。基因型对表型的影响。
J Clin Invest. 1993 Nov;92(5):2291-302. doi: 10.1172/JCI116833.

引用本文的文献

1
Expanding the Clinical and Genetic Spectra of Primary Immunodeficiency-Related Disorders With Clinical Exome Sequencing: Expected and Unexpected Findings.采用临床外显子组测序拓展原发性免疫缺陷相关疾病的临床与遗传谱:意料之中和意料之外的发现。
Front Immunol. 2019 Oct 1;10:2325. doi: 10.3389/fimmu.2019.02325. eCollection 2019.
2
A novel mutation in the ADA gene causing severe combined immunodeficiency in an Arab patient: a case report.ADA基因中的一种新型突变导致一名阿拉伯患者出现严重联合免疫缺陷:病例报告。
J Med Case Rep. 2009 Apr 1;3:6799. doi: 10.1186/1752-1947-3-6799.
3
The binding site of human adenosine deaminase for CD26/Dipeptidyl peptidase IV: the Arg142Gln mutation impairs binding to cd26 but does not cause immune deficiency.

本文引用的文献

1
Genetic heterogeneity in partial adenosine deaminase deficiency.部分腺苷脱氨酶缺乏症中的遗传异质性。
J Clin Invest. 1983 Jun;71(6):1887-92. doi: 10.1172/jci110944.
2
Adenosine deaminase deficiency with normal immune function. An acidic enzyme mutation.具有正常免疫功能的腺苷脱氨酶缺乏症。一种酸性酶突变。
J Clin Invest. 1983 Aug;72(2):483-92. doi: 10.1172/jci110996.
3
"A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity". Addendum.一种将DNA限制性内切酶片段放射性标记至高比活度的技术。附录
人腺苷脱氨酶与CD26/二肽基肽酶IV的结合位点:Arg142Gln突变损害与CD26的结合,但不引起免疫缺陷。
J Exp Med. 2000 Nov 6;192(9):1223-36. doi: 10.1084/jem.192.9.1223.
4
Adenosine deaminase deficiency: genotype-phenotype correlations based on expressed activity of 29 mutant alleles.腺苷脱氨酶缺乏症:基于29个突变等位基因表达活性的基因型-表型相关性
Am J Hum Genet. 1998 Oct;63(4):1049-59. doi: 10.1086/302054.
5
Clinical expression, genetics and therapy of adenosine deaminase (ADA) deficiency.腺苷脱氨酶(ADA)缺乏症的临床表型、遗传学及治疗
J Inherit Metab Dis. 1997 Jun;20(2):179-85. doi: 10.1023/a:1005300621350.
6
Somatic mosaicism for a newly identified splice-site mutation in a patient with adenosine deaminase-deficient immunodeficiency and spontaneous clinical recovery.一名腺苷脱氨酶缺乏性免疫缺陷且有自发临床康复的患者中,新发现的剪接位点突变的体细胞镶嵌现象。
Am J Hum Genet. 1994 Jul;55(1):59-68.
7
Homozygosity for a newly identified missense mutation in a patient with very severe combined immunodeficiency due to adenosine deaminase deficiency (ADA-SCID).一名因腺苷脱氨酶缺乏导致极重型联合免疫缺陷(ADA-SCID)的患者,其新发现的错义突变呈纯合状态。
Am J Hum Genet. 1991 Oct;49(4):878-85.
8
Four different mutations in codon 28 of alpha spectrin are associated with structurally and functionally abnormal spectrin alpha I/74 in hereditary elliptocytosis.α-血影蛋白第28密码子的四种不同突变与遗传性椭圆形红细胞增多症中结构和功能异常的血影蛋白αI/74相关。
J Clin Invest. 1991 Sep;88(3):743-9. doi: 10.1172/JCI115371.
9
Insulin-dependent diabetes mellitus and severe atopic dermatitis in a child with adenosine deaminase deficiency.一名患有腺苷脱氨酶缺乏症儿童的胰岛素依赖型糖尿病和重度特应性皮炎。
Eur J Pediatr. 1992 Nov;151(11):811-4. doi: 10.1007/BF01957930.
Anal Biochem. 1984 Feb;137(1):266-7. doi: 10.1016/0003-2697(84)90381-6.
4
DNA methylation and the frequency of CpG in animal DNA.DNA甲基化与动物DNA中CpG的频率
Nucleic Acids Res. 1980 Apr 11;8(7):1499-504. doi: 10.1093/nar/8.7.1499.
5
Adenosine deaminase deficiency without immunodeficiency: clinical and metabolic studies.无免疫缺陷的腺苷脱氨酶缺乏症:临床与代谢研究
Pediatr Res. 1980 Jul;14(7):885-9. doi: 10.1203/00006450-198007000-00009.
6
Efficient isolation of genes by using antibody probes.使用抗体探针高效分离基因。
Proc Natl Acad Sci U S A. 1983 Mar;80(5):1194-8. doi: 10.1073/pnas.80.5.1194.
7
Structure of adenosine deaminase mRNAs from normal and adenosine deaminase-deficient human cell lines.来自正常和腺苷脱氨酶缺陷型人类细胞系的腺苷脱氨酶mRNA的结构
Mol Cell Biol. 1984 Sep;4(9):1712-7. doi: 10.1128/mcb.4.9.1712-1717.1984.
8
A simple and very efficient method for generating cDNA libraries.一种简单且非常有效的生成cDNA文库的方法。
Gene. 1983 Nov;25(2-3):263-9. doi: 10.1016/0378-1119(83)90230-5.
9
Restriction sites containing CpG show a higher frequency of polymorphism in human DNA.含有CpG的限制性酶切位点在人类DNA中显示出更高的多态性频率。
Cell. 1984 Jan;36(1):131-8. doi: 10.1016/0092-8674(84)90081-3.
10
Human adenosine deaminase. cDNA and complete primary amino acid sequence.人腺苷脱氨酶。cDNA及完整的一级氨基酸序列。
J Biol Chem. 1984 Oct 10;259(19):12101-6.